Mitildzans Androniks, Arechvo Anastasija, Rezeberga Dace, Isajevs Sergejs
Department of Oncology, Riga East University Hospital, Riga, Latvia.
Turk Patoloji Derg. 2017;33(1):9-16. doi: 10.5146/tjpath.2016.01373.
Cervical intraepithelial neoplasia (CIN) is a dysplastic process in cervical squamous epithelium and carries a risk of progression to cervical cancer. The aim of this study was to compare expression of three biomarkers named p53, p63 and Ki-67 in patients with various grades of cervical intraepithelial neoplasia and in a control group.
58 patients were enrolled in the study. Each patient underwent a colposcopy-guided biopsy of the cervix. Immunostaining for markers (p53, p63 and Ki-67) was performed on tissue samples of normal cases (n=10), CIN I (n=20), CIN II (n=14), and CIN III (n=14).
Our study showed a significant increase of the expression of the analyzed biomarkers in most patients with CIN III compared to CIN II and CIN I. Furthermore, p53 and p63 were significantly increased in CIN I compared to the control group.
The expression of Ki-67, p63 and p53 differed between CIN I, CIN II and CIN III. p63 and p53 were reliable biomarkers to distinguish reactive changes from CIN I, while all three biomarkers (Ki-67, p53 and p63) had a high degree of sensitivity and specificity to distinguish between CIN III, CIN II and CIN I.
宫颈上皮内瘤变(CIN)是宫颈鳞状上皮的发育异常过程,具有发展为宫颈癌的风险。本研究的目的是比较不同级别宫颈上皮内瘤变患者及对照组中三种生物标志物p53、p63和Ki-67的表达情况。
58例患者纳入本研究。每位患者均接受阴道镜引导下的宫颈活检。对正常病例(n = 10)、CIN I(n = 20)、CIN II(n = 14)和CIN III(n = 14)的组织样本进行标志物(p53、p63和Ki-67)免疫染色。
我们的研究表明,与CIN II和CIN I相比,大多数CIN III患者中所分析生物标志物的表达显著增加。此外,与对照组相比,CIN I中p53和p63显著增加。
Ki-67、p63和p53在CIN I、CIN II和CIN III之间的表达存在差异。p63和p53是区分CIN I反应性改变的可靠生物标志物,而所有三种生物标志物(Ki-67、p53和p63)在区分CIN III、CIN II和CIN I方面具有高度的敏感性和特异性。